SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $43.80 | 52-week high | $48.76 |
| Prev. close | $42.30 | 52-week low | $38.88 |
| Day low | $42.61 | Volume | 172,000 |
| Day high | $44.14 | Avg. volume | 49,975 |
| 50-day MA | $44.33 | Dividend yield | 1.56% |
| 200-day MA | $43.89 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 165.21M |
| Net Asset Value (NAV) | $42.36 |
| Options? | Yes |
| Total Holdings | 45 |
XPH Top Holdings
| Symbol | Company | % of Total |
| ELAN | ELANCO ANIMAL HEALTH INC | 3.82% |
| CORT | CORCEPT THERAPEUTICS INC | 3.78% |
| TARS | TARSUS PHARMACEUTICALS INC | 3.75% |
| ZTS | ZOETIS INC | 3.75% |
| AXSM | AXSOME THERAPEUTICS INC | 3.74% |
| PRGO | PERRIGO CO PLC | 3.71% |
| ITCI | INTRA CELLULAR THERAPIES INC | 3.68% |
| JNJ | JOHNSON + JOHNSON | 3.68% |
| LLY | ELI LILLY + CO | 3.67% |
| BMY | BRISTOL MYERS SQUIBB CO | 3.62% |
XPH Price Returns
| 1-mo | -1.36% |
| 3-mo | N/A |
| 6-mo | 0.18% |
| 1-year | 4.30% |
| 3-year | -0.39% |
| 5-year | 32.75% |
| YTD | 2.24% |
| 2024 | 4.94% |
| 2023 | 2.97% |
| 2022 | -9.83% |
| 2021 | -10.54% |
| 2020 | 14.68% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||